Skip to main content
. Author manuscript; available in PMC: 2009 Apr 1.
Published in final edited form as: Diabetes. 2007 Dec 27;57(4):809–816. doi: 10.2337/db07-1238

TABLE 1.

Characteristics of PPARGC1A SNPs genotyped in 959 subjects

SNP name* rs no. HUGO name Distance from TSS (bp) Gene region Minor allele frequency
m9722 rs10030083 NT_006316.15g0.14767780C>A −9,722 Upstream 0.19 ± 0.01
m1668 rs2970869 NT_006316.15g0.14568727G>A −1,668 Upstream 0.26 ± 0.01
i5378 rs2946385 NM_013261.3r0.234 + 52G>T 5,378 Intron 2 0.43 ± 0.02
i15867 Rs10028665 NM_013261.3r0.234 + 10541C>T 15,867 Intron 2 0.16 ± 0.01
i27289 rs4235308 NM_013261.3r0.2:34 + 21963A>G 27,289 Intron 2 0.39 ± 0.02
i55301 rs4697046 NM_013261.3r0.235–3026A>G 55,301 Intron 2 0.37 ± 0.02
G482S rs8192678 NP_037393.1p.Gly482Ser 76,089 Exon 8 0.29 ± 0.01
T612M rs3736265 NP_037393.1p.Thr612Met 76,994 Exon 9 0.06 ± 0.01
3U4898 rs3774923 NM_013261.3r0.4778G>A 96,637 3′-Untranslated region, exon 13 0.04 ± 0.01

Data are means ± SE.

*

m indicates a SNP is located in the promoter or upstream of the gene; i is in the intron; 3U is in the 3′-untranslated region; and others are substitution changes in exons.

HUGO names of SNPs are based on nomenclature recommendations of the Human Genome Variation Society (http:/www.hgvs.org/rec.html).

TSS, transcription start site.